• 1 year outcomes in a multicenter randomized trial comparing MISAGO® vs. ZILVER® PTX® for the treatment of intermediate length femoropopliteal lesions

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details